[HTML][HTML] Dominant-negative suppression of HNF-1α function results in defective insulin gene transcription and impaired metabolism-secretion coupling in a pancreatic …

H Wang, P Maechler, KA Hagenfeldt… - The EMBO journal, 1998 - embopress.org
H Wang, P Maechler, KA Hagenfeldt, CB Wollheim
The EMBO journal, 1998embopress.org
Mutations in the hepatocyte nuclear factor-1α (HNF-1α) have been linked to subtype 3 of
maturity-onset diabetes of the young (MODY3), which is characterized by a primary defect in
insulin secretion. The role of HNF-1α in the regulation of pancreatic β-cell function was
investigated. Gene manipulation allowed graded overexpression of HNF-1α and controlled
dominant-negative suppression of HNF-1α function in insulinoma INS-1 cells. We show that
HNF-1α is essential for insulin gene transcription, as demonstrated by a pronounced …
Mutations in the hepatocyte nuclear factor-1α (HNF-1α) have been linked to subtype 3 of maturity-onset diabetes of the young (MODY3), which is characterized by a primary defect in insulin secretion. The role of HNF-1α in the regulation of pancreatic β-cell function was investigated. Gene manipulation allowed graded overexpression of HNF-1α and controlled dominant-negative suppression of HNF-1α function in insulinoma INS-1 cells. We show that HNF-1α is essential for insulin gene transcription, as demonstrated by a pronounced decrease in insulin mRNA expression and in insulin promoter activity under dominant-negative conditions. The expression of genes involved in glucose transport and metabolism including glucose transporter-2 and L-type pyruvate kinase is also regulated by HNF-1α. Loss of HNF-1α function leads to severe defects in insulin secretory responses to glucose and leucine, resulting from impaired glucose utilization and mitochondrial oxidation. The nutrient-evoked ATP production and subsequent changes in plasma membrane potential and intracellular Ca 2+ were diminished by suppression of HNF-1α function. These results suggest that HNF-1α function is essential for maintaining insulin storage and nutrient-evoked release. The defective mitochondrial oxidation of metabolic substrates causes impaired insulin secretion, indicating a molecular basis for the diabetic phenotype of MODY3 patients.
embopress.org